Spravato vs Ketamine outlines critical differences between two innovative treatments for treatment-resistant depression, empowering individuals to make informed choices about their mental health. Identify Spravato as an FDA-approved nasal spray that offers rapid relief for treatment-resistant depression, administered under strict medical supervision. Recognize ketamine’s off-label use as an IV infusion, where variability in administration and […]
Read More… from Spravato vs Ketamine: Key Differences in Depression Treatment Options